First PREMIER Bank »

Ultragenyx Pharmaceutical shares owned by First PREMIER Bank

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by First PREMIER Bank from 13F filings

Historical chart of First PREMIER Bank investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by First PREMIER Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by First PREMIER Bank

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0k 53 37.74

More positions owned by First PREMIER Bank

Vanguard Total Stock Market Etf Total Stk Mkt (VTI)
Vanguard Value Etf Value Etf (VTV)
Apple (AAPL)
Invesco S&p 500 Downside Hedged Etf S&p500 Downsid (PHDG)
Vanguard Information Technology Etf Inf Tech Etf (VGT)
Microsoft Corporation (MSFT)
Procter & Gamble Company (PG)
Union Pacific Corporation (UNP)
Mastercard Inc Cl A Cl A (MA)
Johnson & Johnson (JNJ)
Berkshire Hathaway Inc Del Cl B Cl B New (BRK.B)
Vanguard High Dividend Yield Etf High Div Yld (VYM)
Invesco S&p 500 Low Volatility Etf S&p500 Low Vol (SPLV)
Southern Company (SO)
Duke Energy Corp Com New (DUK)

View all positions for First PREMIER Bank

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
Wellington Management Company
T. Rowe Price Associates
Federated Investors
ClearBridge Advisors
Alliancebernstein
Marshall Wace
Baker Bros. Advisors
Deutsche Bank Aktiengesellschaft
Bank of New York Mellon
Avidity Partners Management
Norges Bank Investment Management
First Light Asset Management
Jacobs Levy Equity Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Ultragenyx Pharmaceutical